Skip to main content
. 2022 Feb 28;56(3):126–133. doi: 10.4132/jptm.2022.01.04

Table 4.

Mutational status of PIK3CA in HNSCC

Sample No. Age at diagnosis (yr) Sex Tumor location Exon Nucleotide Codon change Amino acid change Type of mutation
PS212 76 Male Pyriform sinus 9 G1633A GAG to AAG E545K Missense
PS220 62 Female Pyriform sinus 9 G1633A GAG to AAG E545K Missense
PS243 72 Male Pyriform sinus 20 A3140G CAT to CGT H1047R Missense
PS251/1 63 Male Pyriform sinus 20 C3075T ACC to ACT T1025T Silent
OR183 58 Female Buccal mucosa 20 C3075T ACC to ACT T1025T Silent
OR214 90 Female Tongue 20 C3075T ACC to ACT T1025T Silent
OR378 79 Female Gums 20 C3075T ACC to ACT T1025T Silent
OR391 69 Male Floor of mouth 20 C3075T ACC to ACT T1025T Silent
OR205 79 Female Lip 20 A3140G CAT to CGT H1047R Missense
OR209 66 Female Lip 20 A3140G CAT to CGT H1047R Missense

PIK3CA, phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha; HNSCC, head and neck squamous cell carcinoma.